首页 | 本学科首页   官方微博 | 高级检索  
检索        


Indoor air pollutants in office environments: Assessment of comfort,health, and performance
Authors:Peder Wolkoff
Institution:National Research Centre for the Working Environment, Copenhagen, Denmark
Abstract:Concentrations of volatile organic compounds (VOCs) in office environments are generally too low to cause sensory irritation in the eyes and airways on the basis of estimated thresholds for sensory irritation. Furthermore, effects in the lungs, e.g. inflammatory effects, have not been substantiated at indoor relevant concentrations. Some VOCs, including formaldehyde, in combination may under certain environmental and occupational conditions result in reported sensory irritation. The odour thresholds of several VOCs are low enough to influence the perceived air quality that result in a number of acute effects from reported sensory irritation in eyes and airways and deterioration of performance. The odour perception (air quality) depends on a number of factors that may influence the odour impact. There is neither clear indication that office dust particles may cause sensory effects, even not particles spiked with glucans, aldehydes or phthalates, nor lung effects; some inflammatory effects may be observed among asthmatics. Ozone-initiated terpene reaction products may be of concern in ozone-enriched environments (≥0.1 mg/m3) and elevated limonene concentrations, partly due to the production of formaldehyde. Ambient particles may cause cardio-pulmonary effects, especially in susceptible people (e.g. elderly and sick people); even, short-term effects, e.g. from traffic emission and candle smoke may possibly have modulating and delayed effects on the heart, but otherwise adverse effects in the airways and lung functions have not been observed. Secondary organic aerosols generated in indoor ozone-initiated terpene reactions appear not to cause adverse effects in the airways; rather the gaseous products are relevant. Combined exposure to particles and ozone may evoke effects in subgroups of asthmatics.
Keywords:IAQ  indoor air quality  BAL  bronchoalveolar lavage  BP  blood pressure  CC16  inflammatory marker of lung epithelium  CNS  central nervous system  COPD  chronic obstructive pulmonary disease  EDC  endocrine disrupting compounds  DEHP  plasticiser di-(ethylhexyl)phthalate  FEF25&ndash  75  forced expiratory flow  25% and 75%  FEV1  forced expiratory volume  1st second  FVC  forced vital capacity  FeNO  fractional exhaled nitrogen oxide  G-CSF  granulocyte colony-stimulating factor  HR  heart rate  HRV  heart rate variability  IL-6  inflammatory marker in blood  IL-8  inflammatory marker in blood  IL-10  inflammatory marker in blood  LOAEL  lowest observed adverse effect level  MVOC  microbiological VOC  NAL  nasal lavage  NOEL  no observed effect level  NOAEL  no observed adverse effect level  PEF  peak expiratory flow  PM2  5  particles <  2    μm in aerodynamic diameter  PM10  particles <  10   μm in aerodynamic diameter  PN  particle number/cm3  QUATs  quaternary ammonium chlorides  RD50  the concentration that causes 50% reduction in the respiratory rate in rodents  RH  relative humidity  ROS  reactive oxygen species  SOA  secondary organic aerosols  TSP  total suspended particles  SVOC  semi-volatile organic compound  TVOC  total volatile organic compounds (between C6 and C16)  UFP  ultrafine particles (aerodynamic diameter <    μm)  VOC  volatile organic compound
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号